“…Recent years have seen a growth in interest in image and performance enhancing drugs (IPEDs), and the potential risk to public health posed by their use, both in the UK and internationally (Bates & McVeigh, 2016; Bates et al, 2021; Hope et al, 2022; Sagoe & Pallesen, 2018). IPEDs broadly are drugs taken for the purposes of enhancing one’s appearance, sporting performance, sexual function or mood (van de Ven et al, 2019), and are often referred to as “lifestyle medicines,” reflecting the lifestyle-enhancement motivations underpinning much contemporary use (Hall & Antonopoulos, 2016; Kotzé & Antonopoulos, 2021). While the use of IPEDs among sporting competitors and “hardcore” gym cultures (e.g., bodybuilders) has long been explored (Klein, 1995; Monaghan, 2001), recent research has drawn attention to their use among recreational fitness trainers, highlighting a seeming normalization of use among gym-going populations, and other wellness-conscious groups (Brennan et al, 2017; Evans-Brown et al, 2012; Kimergård, 2015; Sagoe et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…While academic discourse around IPEDs increasingly acknowledges the importance of harm reduction for users (Bates et al, 2022), it is clear there remain gaps in our understanding regarding how best to serve specific populations (Hope et al, 2022; McVeigh, Hearne, et al, 2021). With IPED use being highly heterogenous (van de Ven et al, 2019), much work has acknowledged the extent to which interventions must be tailored to the different practices, motivations and harm profiles of users (Christiansen et al, 2017; Harvey et al, 2021; Vinther & Christiansen, 2019). Consequently, a range of user typologies have been developed which attempt to bridge this knowledge gap, with several works looking to match user risk behaviors to factors such as subcultural affiliation or motivations for training, as heuristics for guiding harm reduction (Christiansen et al, 2017; Turnock, 2018; Zahnow et al, 2018).…”
Image and performance enhancing drugs (IPEDs) have been highlighted in recent years as posing a potential risk to public health, with much research dedicated to exploring the use of these drugs and associated harms. While recent work has considered harm reduction for IPED users, the geographic and cultural impacts of rurality on IPED use and harms, particularly in relation to harm reduction service access, remains comparatively under-explored. Features of rurality relating to levels of economic distress, the inheritance and decline of manual labor, and rural conceptions of masculinity are important in shaping drug harms. Consequently, the “rural risk environment” for IPED users is in need of exploration. This research examines the experiences of IPED users in a remote two-county region of rural England, drawn from a multi-year ethnography and 18 qualitative interviews with IPED users, to explore the impacts of rurality and the “rural risk environment” on service access and harm (reduction) within this population. Findings highlight a number of ways in which rurality impacted on IPED users’ access to harm reduction services such as needle and syringe programs (NSP), as well as engagement with healthcare practitioners (HCP). Issues included the distances required to access services and lack of public transport between towns; the impacts of stigma in a small town context where there is little anonymity; Distrust of HCP relating to cultural mindsets and regionally derived fears regarding impacts on employment prospects, particularly military; and the impacts of rural masculinities and perceptions of the self-sufficient “real man” on help-seeking when experiencing harm. The research highlights the need to incorporate cultural geographic understandings into harm reduction policy for IPED users, and the significance of rurality on experiences of harm.
“…Recent years have seen a growth in interest in image and performance enhancing drugs (IPEDs), and the potential risk to public health posed by their use, both in the UK and internationally (Bates & McVeigh, 2016; Bates et al, 2021; Hope et al, 2022; Sagoe & Pallesen, 2018). IPEDs broadly are drugs taken for the purposes of enhancing one’s appearance, sporting performance, sexual function or mood (van de Ven et al, 2019), and are often referred to as “lifestyle medicines,” reflecting the lifestyle-enhancement motivations underpinning much contemporary use (Hall & Antonopoulos, 2016; Kotzé & Antonopoulos, 2021). While the use of IPEDs among sporting competitors and “hardcore” gym cultures (e.g., bodybuilders) has long been explored (Klein, 1995; Monaghan, 2001), recent research has drawn attention to their use among recreational fitness trainers, highlighting a seeming normalization of use among gym-going populations, and other wellness-conscious groups (Brennan et al, 2017; Evans-Brown et al, 2012; Kimergård, 2015; Sagoe et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…While academic discourse around IPEDs increasingly acknowledges the importance of harm reduction for users (Bates et al, 2022), it is clear there remain gaps in our understanding regarding how best to serve specific populations (Hope et al, 2022; McVeigh, Hearne, et al, 2021). With IPED use being highly heterogenous (van de Ven et al, 2019), much work has acknowledged the extent to which interventions must be tailored to the different practices, motivations and harm profiles of users (Christiansen et al, 2017; Harvey et al, 2021; Vinther & Christiansen, 2019). Consequently, a range of user typologies have been developed which attempt to bridge this knowledge gap, with several works looking to match user risk behaviors to factors such as subcultural affiliation or motivations for training, as heuristics for guiding harm reduction (Christiansen et al, 2017; Turnock, 2018; Zahnow et al, 2018).…”
Image and performance enhancing drugs (IPEDs) have been highlighted in recent years as posing a potential risk to public health, with much research dedicated to exploring the use of these drugs and associated harms. While recent work has considered harm reduction for IPED users, the geographic and cultural impacts of rurality on IPED use and harms, particularly in relation to harm reduction service access, remains comparatively under-explored. Features of rurality relating to levels of economic distress, the inheritance and decline of manual labor, and rural conceptions of masculinity are important in shaping drug harms. Consequently, the “rural risk environment” for IPED users is in need of exploration. This research examines the experiences of IPED users in a remote two-county region of rural England, drawn from a multi-year ethnography and 18 qualitative interviews with IPED users, to explore the impacts of rurality and the “rural risk environment” on service access and harm (reduction) within this population. Findings highlight a number of ways in which rurality impacted on IPED users’ access to harm reduction services such as needle and syringe programs (NSP), as well as engagement with healthcare practitioners (HCP). Issues included the distances required to access services and lack of public transport between towns; the impacts of stigma in a small town context where there is little anonymity; Distrust of HCP relating to cultural mindsets and regionally derived fears regarding impacts on employment prospects, particularly military; and the impacts of rural masculinities and perceptions of the self-sufficient “real man” on help-seeking when experiencing harm. The research highlights the need to incorporate cultural geographic understandings into harm reduction policy for IPED users, and the significance of rurality on experiences of harm.
“…Yet, despite references to PIEDs as an apparently stable, unified category, on further scrutiny it becomes clear that the boundaries of the category are contested and mutable: different drugs and consumption practices have been classified under its ambit, and these have changed over time. Van de Ven et al (2019) describe some of these historical tensions in the constitution of PIEDs as a category, observing how the contextual boundaries of the category have shifted over the last two decades in relation to changing social concerns that the category PIEDs indexes: previously the category centered on "doping" in sport, but it has expanded to include the consumption of these drugs in other athletic and occupational settings. They write that "the main goals of these 'non-athletic' using groups is aesthetic modification, such as to lose weight or to increase muscle mass, and to a lesser extent, athletic enhancement" (p. 4).…”
Section: Interrogating the Category Of Performance And Image-enhancin...mentioning
Women’s “performance and image-enhancing drug consumption” is a growing phenomenon yet remains an under-studied area of research. This essay reviews the existing literature on women’s consumption and draws on Fraser’s concept of ontopolitically-oriented research to develop an agenda for future research. Ontopolitically-oriented research applies insights from Science and Technology Studies (STS) to consider the ontological politics of research practices, that is, the realities they enact and foreclose. We argue that the current focus in the existing literature on a limited set of methods and issues risks obscuring the diverse meanings and practices of women’s substance consumption for fitness and strength-training, and genders agency in ways that further entrench assumptions of women’s vulnerability and passivity. We consider issues pertaining to the nomenclature of performance and image-enhancing drugs, the gendering of agency in formulations of “health” risks and initiation experiences, and the need to understand women’s consumption practices in relation to broader cultural changes in health optimization and digital fitness cultures. We argue that ontopolitically-oriented research into women’s substance consumption for fitness and strength-training requires greater methodological diversity and attention to the politics of data generation. It should aim to constitute women’s experiences through terms, connections and coalitions that expand our understandings of women’s agency, and the gendered and social contexts of enhancement practices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.